Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study
- PMID: 22125624
- PMCID: PMC3220679
- DOI: 10.1371/journal.pone.0027784
Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study
Abstract
Background: Progressive lung disease accounts for the majority of morbidity and mortality observed in cystic fibrosis (CF). Beyond secondhand smoke exposure and socio-economic status, the effect of specific environmental factors on CF lung function is largely unknown.
Methods: Multivariate regression was used to assess correlation between specific environmental factors, the presence of pulmonary pathogens, and variation in lung function using subjects enrolled in the U.S. CF Twin and Sibling Study (CFTSS: n = 1378). Significant associations were tested for replication in the U.S. CF Foundation Patient Registry (CFF: n = 16439), the Australian CF Data Registry (ACFDR: n = 1801), and prospectively ascertained subjects from Australia/New Zealand (ACFBAL: n = 167).
Results: In CFTSS subjects, the presence of Pseudomonas aeruginosa (OR = 1.06 per °F; p<0.001) was associated with warmer annual ambient temperatures. This finding was independently replicated in the CFF (1.02; p<0.001), ACFDR (1.05; p = 0.002), and ACFBAL (1.09; p = 0.003) subjects. Warmer temperatures (-0.34 points per °F; p = 0.005) and public insurance (-6.43 points; p<0.001) were associated with lower lung function in the CFTSS subjects. These findings were replicated in the CFF subjects (temperature: -0.31; p<0.001; insurance: -9.11; p<0.001) and similar in the ACFDR subjects (temperature: -0.23; p = 0.057). The association between temperature and lung function was minimally influenced by P. aeruginosa. Similarly, the association between temperature and P. aeruginosa was largely independent of lung function.
Conclusions: Ambient temperature is associated with prevalence of P. aeruginosa and lung function in four independent samples of CF patients from two continents.
Conflict of interest statement
Similar articles
-
Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis.J Cyst Fibros. 2016 Nov;15(6):794-801. doi: 10.1016/j.jcf.2016.05.012. Epub 2016 Jun 11. J Cyst Fibros. 2016. PMID: 27296562 Free PMC article.
-
Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens. A Cohort Study Using National Registry Data.Ann Am Thorac Soc. 2019 Nov;16(11):1375-1382. doi: 10.1513/AnnalsATS.201902-122OC. Ann Am Thorac Soc. 2019. PMID: 31319678
-
Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis-data from the European cystic fibrosis society patient registry.J Cyst Fibros. 2020 May;19(3):376-383. doi: 10.1016/j.jcf.2019.08.006. Epub 2019 Sep 3. J Cyst Fibros. 2020. PMID: 31492646
-
Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.BMC Pulm Med. 2016 Dec 5;16(1):174. doi: 10.1186/s12890-016-0339-5. BMC Pulm Med. 2016. PMID: 27919253 Free PMC article. Review.
-
Microbial ecology of the cystic fibrosis lung.Microbiology (Reading). 2007 Apr;153(Pt 4):917-923. doi: 10.1099/mic.0.2006/004077-0. Microbiology (Reading). 2007. PMID: 17379702 Review.
Cited by
-
Environmental allergies and respiratory morbidities in cystic fibrosis.Pediatr Pulmonol. 2013 Sep;48(9):857-64. doi: 10.1002/ppul.22700. Epub 2012 Nov 9. Pediatr Pulmonol. 2013. PMID: 23143815 Free PMC article.
-
Treatment satisfaction in cystic fibrosis: early patient experience with tobramycin inhalation powder.Patient Prefer Adherence. 2016 Oct 26;10:2163-2169. doi: 10.2147/PPA.S102234. eCollection 2016. Patient Prefer Adherence. 2016. PMID: 27822017 Free PMC article.
-
The association between ambient temperature and children's lung function in Baotou, China.Int J Biometeorol. 2015 Jul;59(7):791-8. doi: 10.1007/s00484-014-0897-2. Epub 2014 Sep 19. Int J Biometeorol. 2015. PMID: 25234750
-
2024 ASHG presidential address: Incomplete penetrance and variable expressivity: Old concepts, new urgency.Am J Hum Genet. 2025 Mar 6;112(3):461-466. doi: 10.1016/j.ajhg.2025.01.010. Am J Hum Genet. 2025. PMID: 40054435
-
The influence of genetics on cystic fibrosis phenotypes.Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a009548. doi: 10.1101/cshperspect.a009548. Cold Spring Harb Perspect Med. 2012. PMID: 23209180 Free PMC article.
References
-
- Kerem E, Corey M, Kerem B-S, Rommens J, Markiewicz D, et al. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (deltaF508). N Engl J Med. 1990;323:1517–1522. - PubMed
-
- The Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med. 1993;329:1308–1313. - PubMed
-
- Koch C, Cuppens H, Rainisio M, Madessani U, Harms H, et al. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol. 2001;31:1–12. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical